Moreover, we have shown that steady-state levels of 5LO are increased in brain frontal cortices from subjects with a post-mortem diagnosis of PSP and that pharmacologic blockade of the 5LO activation ameliorates tau pathology and behavioral deficits in a mouse model expressing human tau, the h-tau mice23. Here, MAPT is linked to supranuclear palsy, progressive, 1.